Trial intelligence / Profile preview

Zinc sulfate for neonatal jaundice

NCT05161611Completed

Sponsor
Makassed General Hospital
Start
Dec 2021
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in jaundice comparing Zinc sulfate Arm with Placebo Arm (2 arms). Primary endpoint: Phototherapy duration at 1 week. Started Dec 2021; status: completed.

02

Drugs

zinc
03

Conditions

jaundice

Beyond the preview

Go deeper on NCT05161611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05161611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call